SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Josh C. Pleasure, M.D. who wrote ()7/14/1996 11:57:00 PM
From: Dr. A. Zeev Hed   of 371
 
Josh: Welcome aboard. I thought we had another (relatively quite) thread on IMMU. In any event, I think the next move might be in sympathy with a powerful rally in technology. I also think that additional events or news in the forthcoming weeks will precede FDA aproval of Leukoscan, such as the pending of a major publication in a leading medical magazine on the methodologies of using CEA-Scan for the specific cancer imaging already approved by the FDA, and probably the approval of CEA-Scan in some European or even Asian countries. The latter could bring a marketing agreement in Japan (no fact, but great hopes).

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext